hesperetin and Cancer of Lung

hesperetin has been researched along with Cancer of Lung in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Yu, Z; Zhang, X1
Chen, Y; Kong, W; Lai, G; Ling, X; Wang, S; Wang, W; Wu, X; Yu, Z; Zhao, Z1
Alshatwi, AA; Athinarayanan, J; Elango, R; Lei, DKY; Subbarayan, VP1
Dong, W; Du, J; Huang, C; Liu, S; Qu, X; Wang, Y; Yan, T1
Boom, K; Borsoi, C; Celia, C; Ferrari, M; Fresta, M; Grande, R; Scott, B; Shen, H; Shen, J; Suri, K; Wolfram, J; Zhao, Y1
Albuquerque, RM; Beraldo, H; de Azevedo, RA; Ferreira, AK; Gouvea, LR; Louro, SR; Sousa, AC; Tamayo, LV; Teixeira, SF1
Aromaa, A; Hakulinen, T; Heliövaara, M; Järvinen, R; Knekt, P; Kumpulainen, J; Reunanen, A; Rissanen, H1

Other Studies

7 other study(ies) available for hesperetin and Cancer of Lung

ArticleYear
Pathological analysis of hesperetin-derived small cell lung cancer by artificial intelligence technology under fiberoptic bronchoscopy.
    Mathematical biosciences and engineering : MBE, 2021, 09-30, Volume: 18, Issue:6

    Topics: Artificial Intelligence; Bronchoscopy; Fiber Optic Technology; Hesperidin; Humans; Lung Neoplasms; Small Cell Lung Carcinoma; Technology

2021
Hesperetin reverses P‑glycoprotein‑mediated cisplatin resistance in DDP‑resistant human lung cancer cells via modulation of the nuclear factor‑κB signaling pathway.
    International journal of molecular medicine, 2020, Volume: 45, Issue:4

    Topics: A549 Cells; Animals; ATP Binding Cassette Transporter, Subfamily B; Cisplatin; Drug Resistance, Neoplasm; Hesperidin; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Proteins; Signal Transduction; Transcription Factor RelA

2020
Hesperetin induces an apoptosis-triggered extrinsic pathway and a p53- independent pathway in human lung cancer H522 cells.
    Journal of Asian natural products research, 2018, Volume: 20, Issue:6

    Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoprevention; Gene Expression; Hesperidin; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial

2018
Combination of hesperetin and platinum enhances anticancer effect on lung adenocarcinoma.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 113

    Topics: A549 Cells; Adenocarcinoma of Lung; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Disease Progression; Glucuronosyltransferase; Hesperidin; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Platinum Compounds; Reactive Oxygen Species; Xenograft Model Antitumor Assays

2019
Hesperetin Liposomes for Cancer Therapy.
    Current drug delivery, 2016, Volume: 13, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cholesterol; Drug Compounding; Drug Resistance, Neoplasm; Female; Hesperidin; Humans; Kinetics; Liposomes; Lung Neoplasms; Phosphatidylcholines; Polyethylene Glycols; Solubility; Transfection

2016
Copper(II) complexes with naringenin and hesperetin: cytotoxic activity against A 549 human lung adenocarcinoma cells and investigation on the mode of action.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2016, Volume: 29, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Copper; DNA; Fibroblasts; Flavanones; Hesperidin; Human Umbilical Vein Endothelial Cells; Humans; Lung Neoplasms

2016
Flavonoid intake and risk of chronic diseases.
    The American journal of clinical nutrition, 2002, Volume: 76, Issue:3

    Topics: Adult; Arthritis, Rheumatoid; Asthma; Cataract; Cerebrovascular Disorders; Chronic Disease; Diabetes Mellitus, Type 2; Diet; Female; Flavanones; Flavonoids; Hesperidin; Humans; Kaempferols; Lung Neoplasms; Male; Middle Aged; Mortality; Myocardial Ischemia; Neoplasms; Prostatic Neoplasms; Quercetin; Risk; Risk Factors; Surveys and Questionnaires

2002